Skip to main content
Yanjiu Conference logo

Call for Papers – ICCGETA 2027, Singapore

International Conference on CRISPR Gene Editing and Therapeutic Applications — ICCGETA 2027

Dates

18–19 January 2027

Venue

Singapore, Singapore

Field

CRISPR Gene Editing and Therapeutic Applications

Topics of ICCGETA 2027

Original papers are invited in CRISPR Gene Editing and Therapeutic Applications. Submit by 17 December 2026.

Submit Your Paper

Topics include, but are not limited to:

Mechanisms of CRISPR-Cas Systems

  • Characterization of CRISPR-Cas variants
  • Functional genomics of gene editing
  • Mechanisms of specificity and efficiency

Therapeutic Applications of CRISPR

  • Gene therapies for genetic disorders
  • CRISPR applications in cancer treatment
  • Optimizing delivery systems for therapies

Ethical and Regulatory Considerations

  • Ethical implications of gene editing
  • Regulatory frameworks across countries
  • Public perception and acceptance of CRISPR

CRISPR in Crop Improvement

  • Genetic modification for agricultural resilience
  • CRISPR technologies for pathogen resistance
  • Sustainable practices in crop management

Emerging Technologies in CRISPR Research

  • Integration of AI in CRISPR design
  • Novel delivery methods for CRISPR
  • Cross-disciplinary approaches to gene editing

Challenges in CRISPR Implementation

  • Off-target effects and mitigation strategies
  • Developing robust clinical trials
  • Long-term effects of gene edits on populations

Important Dates

Conference opens in

00days
00hours
00min
00sec
  1. Step 1

    Submission Deadline

  2. Step 2

    Registration Deadline

  3. Step 3

    Conference Date

Download

Get the official templates and forms for ICCGETA 2027. Use the latest versions when preparing your submission.

Peer Review Process

Follow each step from abstract submission to awards and recognition.

Yanjiuconference peer review process: 12 steps from abstract submission to awards and recognition

See You in Singapore This January

Present your research, meet peers from over 50 countries and help shape the future of CRISPR Gene Editing and Therapeutic Applications.